ObsEva SA

(NASDAQ:OBSV)

Latest On ObsEva SA (OBSV):

Date/Time Type Description Signal Details
2023-03-15 14:57 ESTNewsObsEva to delist from Nasdaq next week with eye on consolidating Swiss opsN/A
2023-02-24 20:51 ESTNewsObsEva to delist from Nasdaq in companywide shake upN/A
2022-12-14 20:50 ESTNewsObsEva demonstrates compliance with Nasdaq stockholders equity ruleN/A
2022-12-09 22:24 ESTNewsObsEva to increase share capital with issuance of new treasury stockN/A
2022-12-02 09:12 ESTNewsObsEva GAAP EPS of -$0.13 misses by $0.03, revenue of $3.71M beats by $1.21MN/A
2022-11-23 00:20 ESTNewsXOMA assumes the rights to ebopiprant from ObsEvaN/A
2022-11-04 23:54 ESTNewsObsEva Q3 2022 Earnings PreviewN/A
2022-09-13 15:35 ESTNewsObsEva to cut 70% of workforceN/A
2022-08-23 07:03 ESTNewsObsEva stock dips on Nasdaq non-compliance noticeN/A
2022-08-01 14:04 ESTNewsObsEva to retire $31M in debt and announces $11M debt refinancingN/A
2022-07-27 08:15 ESTNewsObsEva drops 78% on plans for restructuring after setback for uterine fibroids drugN/A
2022-07-05 17:38 ESTNewsObsEva: Ignored, But Long-Term Prospects Exist On Recent ProgressN/A
2022-06-29 02:52 ESTNewsObsEva gets UK nod for uterine fibroids therapyN/A
2022-06-17 17:06 ESTNewsObsEva granted European nod for uterine fibroids therapyN/A
2022-05-17 14:22 ESTNewsObsEva GAAP EPS of -$0.14 beats by $0.11N/A
2022-05-17 14:21 ESTNewsObsEva SA (OBSV) CEO Brian O'Callaghan on Q1 2022 Results - Earnings Call TranscriptN/A
2022-03-10 19:56 ESTNewsObsEva GAAP EPS of -$0.78 misses by $0.05, revenue of $20.11M in-lineN/A
2022-02-11 07:14 ESTNewsObsEva inks licensing deal with Theramex for commercialization of linzagolixN/A
2022-02-05 00:56 ESTNewsObsEva warns a potential delay in European marketing authorization for linzagolixN/A
2022-02-01 12:43 ESTNewsObsEva gains after naming chief strategy officerN/A
2022-01-29 04:30 ESTNewsObsEva increases shares capital; amends deal for convertible debt financingN/A
2022-01-06 16:19 ESTNewsObsEva gains 6% on positive linzagolix data in Phase 3 endometriosis pain studyN/A
2021-12-17 07:53 ESTNewsObsEva on track for European approval of uterine fibroids therapyN/A
2021-12-13 05:13 ESTNewsObsEva appoints Will Brown as new finance chiefN/A
2021-11-22 07:22 ESTNewsFDA accepts for review Obseva's linzagolix application for uterine fibroidsN/A
2021-11-04 14:00 ESTNewsObsEva EPS beats by $0.23N/A
2021-10-29 22:18 ESTNewsObsEva finance chief steps downN/A
2021-10-14 02:39 ESTNewsObsEva reports relationship with Syneos Health to commercialize linzagolixN/A
2021-09-22 02:33 ESTNewsObsEva submits linzagolix NDA in U.S. for uterine fibroidsN/A
2021-08-10 09:06 ESTNewsObsEva: Developing Treatments For WomenN/A
2021-08-05 10:26 ESTNewsObsEva EPS beats by $0.01N/A
2021-08-04 12:44 ESTNewsObsEva's nolasiban shows potential to increase pregnancy rates following IVFN/A
2021-07-27 14:17 ESTNewsOrganon, ObsEva ink ebopiprant licensing deal for preterm laborN/A
2021-07-27 14:16 ESTNewsOragenics, EyeGate Pharmaceuticals leads healthcare gainers; Infinity Pharmaceuticals, NanoVibronix among major losersN/A
2021-07-21 18:07 ESTNewsObsEva presents data from Phase 2a PROLONG study in spontaneous preterm labor at RCOG 2021N/A
2021-07-21 17:55 ESTNewsObsEva presents Yselty data in severe adenomyosis at ESHRE 37th Annual MeetingN/A
2021-03-16 21:37 ESTAnalyst RatingThe Analyst Target Price has increased from $11.67 to $13.Buy
2021-03-09 21:20 ESTNewsObsEva readies $50 million worth common stock offeringN/A
2021-03-08 12:14 ESTEarnings EstimateAn EPS average of -$1.23 is estimated for the 2022 year.Sell
2021-03-08 12:14 ESTEarnings EstimateAn EPS average of -$0.35 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-07 04:07 ESTFinancialsCompany financials have been released.Neutral
2021-03-05 02:41 ESTNewsObsEva EPS beats by $0.12N/A
2021-02-19 14:11 ESTNewsObsEva shares rise amid bullish prospects for women's reproductive health companyN/A
2021-01-21 12:41 ESTNewsOur Take On ObsEvaN/A
2021-01-13 12:18 ESTAnalyst RatingThe Analyst Target Price has decreased from $11.83 to $11.67.Neutral
2021-01-11 21:19 ESTNewsObsEva stops US Phase 3 study with Yselty for endometriosisN/A
2021-01-05 12:26 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.83 to $11.83.Neutral
2021-01-04 13:11 ESTNewsObsEva appoints David Renas as CFO; shares +6% PremarketN/A
2020-12-10 16:18 ESTNewsObsEva's linzagolix shows sustained efficacy and continued safety in treatment of uterine fibroidsN/A
2020-11-26 21:03 ESTFinancialsCompany financials have been released.Neutral

About ObsEva SA (OBSV):

ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. The company is developing Linzagolix, an oral gonadotropin-releasing hormone receptor antagonist for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. It also is developing Ebopiprant, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. The company was founded in 2012 and is headquartered in Geneva, Switzerland.

OBSV Quotes by TradingView

See Advanced Chart

General

  • Name ObsEva SA
  • Symbol OBSV
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 42
  • Fiscal Year EndDecember
  • IPO Date2017-01-26
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.obseva.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 9.35
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.03
  • Next Year EPS Estimate -$0.91
  • Next Quarter EPS Estimate -$0.39
  • Operating Margin -468829%
  • Return on Assets -59%
  • Return on Equity -290%
  • Revenue 17000
  • Earnings Per Share -$2.28
  • Revenue Per Share $0
  • Gross Profit 17000
  • Quarterly Earnings Growth 20%
View More

Highlights

  • Market Capitalization 258.52 million
  • EBITDA -98566000
  • Analyst Target Price $13
  • Book Value Per Share $0.15
View More

Share Statistics

  • Shares Outstanding 73.34 million
  • Shares Float 43.96 million
  • % Held by Insiders 554%
  • % Held by Institutions 48.5%
  • Shares Short 2.28 million
  • Shares Short Prior Month 2.18 million
  • Short Ratio 0.44
  • Short % of Float 4%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 0.83
  • 52 Week High $6.3
  • 52 Week Low $1.86
  • 50 Day Moving Average 3.83
  • 200 Day Moving Average 2.78
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

ObsEva SA (OBSV) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

ObsEva SA (OBSV) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-05$N/A-$0.32-$0.4121.43%
2020-09-302020-11-05$N/A-$0.49-$0.33-48.44%
2020-06-302020-08-06$N/A-$0.38-$0.429.89%
2020-03-312020-05-05$N/A-$0.48-$0.47-2.56%
2019-12-312020-03-05$5000-$0.48-$0.6020.36%
2019-09-302019-11-07$5000-$0.63-$0.8223.26%
2019-06-302019-08-07$1000-$0.80-$0.60-34.32%
2019-03-312019-05-09$5000-$0.59-$0.51-15.28%
2018-12-312019-03-05$5000-$0.46-$0.495.43%
2018-09-302018-11-08$2000-$0.42-$0.4811.95%
2018-06-302018-08-08$3000-$0.49-$0.524.85%
2018-03-312018-05-16$5000-$0.54-$0.48-13.68%
2017-12-312018-03-09$5000-$0.48-$0.5512.95%
2017-09-302017-11-14$3000-$0.59-$0.624.65%
2017-06-302017-08-15$2000-$0.61-$0.40-52.5%
2017-03-312017-04-21$6000-$0.50-$0.27-85.19%
2016-12-312017-01-27$22000-$0.38-$0.33-13.94%

ObsEva SA (OBSV) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

ObsEva SA (OBSV) Chart:

ObsEva SA (OBSV) News:

Below you will find a list of latest news for ObsEva SA (OBSV) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

ObsEva SA (OBSV) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest OBSV Trades:

Date Shares Price
Jun 13, 2022 5:32 PM EST100$1.72
Jun 13, 2022 5:32 PM EST300$1.72
Jun 13, 2022 6:51 PM EST200$1.76
Jun 13, 2022 6:51 PM EST100$1.76
Jun 13, 2022 6:52 PM EST200$1.75

ObsEva SA (OBSV) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459020031385/0001564590-20-031385-index.htm
2017-11-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1685316/000000000017040528/0000000000-17-040528-index.htm
2018-02-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1685316/000000000018005266/0000000000-18-005266-index.htm
2018-02-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1685316/000000000018006299/0000000000-18-006299-index.htm
2019-08-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1685316/000000000019012225/0000000000-19-012225-index.htm
2020-09-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1685316/000091957420005860/0000919574-20-005860-index.htm
2017-10-17SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1685316/000107261317000520/0001072613-17-000520-index.htm
2018-02-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1685316/000110465918005883/0001104659-18-005883-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1685316/000110465918009771/0001104659-18-009771-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1685316/000110465919008698/0001104659-19-008698-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1685316/000110465919008751/0001104659-19-008751-index.htm
2020-02-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1685316/000110465920019996/0001104659-20-019996-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1685316/000110465920021726/0001104659-20-021726-index.htm
2017-10-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1685316/000114420417053221/0001144204-17-053221-index.htm
2017-10-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1685316/000114420417054260/0001144204-17-054260-index.htm
2018-01-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1685316/000114420418003113/0001144204-18-003113-index.htm
2018-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1685316/000114420418008780/0001144204-18-008780-index.htm
2018-10-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1685316/000114420418052686/0001144204-18-052686-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1685316/000114420419007794/0001144204-19-007794-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1685316/000117266118000532/0001172661-18-000532-index.htm
2017-08-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312517259175/0001193125-17-259175-index.htm
2017-08-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1685316/000119312517273758/0001193125-17-273758-index.htm
2017-10-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312517307279/0001193125-17-307279-index.htm
2017-11-09F-1Registration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1685316/000119312517338793/0001193125-17-338793-index.htm
2017-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312517342606/0001193125-17-342606-index.htm
2017-11-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1685316/000119312517345457/0001193125-17-345457-index.htm
2017-11-20424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1685316/000119312517348132/0001193125-17-348132-index.htm
2017-11-20424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1685316/000119312517348148/0001193125-17-348148-index.htm
2018-01-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312518001057/0001193125-18-001057-index.htm
2018-01-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312518003581/0001193125-18-003581-index.htm
2018-02-01F-3Registration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1685316/000119312518029449/0001193125-18-029449-index.htm
2018-02-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312518029457/0001193125-18-029457-index.htm
2018-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1685316/000119312518045569/0001193125-18-045569-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1685316/000119312518045664/0001193125-18-045664-index.htm
2018-02-23F-3/ARegistration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1685316/000119312518055336/0001193125-18-055336-index.htm
2018-02-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1685316/000119312518055343/0001193125-18-055343-index.htm
2018-02-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312518058643/0001193125-18-058643-index.htm
2018-02-26424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1685316/000119312518058651/0001193125-18-058651-index.htm
2018-03-01F-3/ARegistration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1685316/000119312518065830/0001193125-18-065830-index.htm
2018-03-01CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1685316/000119312518065850/0001193125-18-065850-index.htm
2018-03-01CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1685316/000119312518066841/0001193125-18-066841-index.htm
2018-03-01POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1685316/000119312518067194/0001193125-18-067194-index.htm
2018-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312518086319/0001193125-18-086319-index.htm
2018-03-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1685316/000119312518086328/0001193125-18-086328-index.htm
2018-03-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312518103434/0001193125-18-103434-index.htm
2018-04-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312518117706/0001193125-18-117706-index.htm
2018-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312518195087/0001193125-18-195087-index.htm
2018-06-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1685316/000119312518196046/0001193125-18-196046-index.htm
2018-06-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1685316/000119312518198135/0001193125-18-198135-index.htm
2018-06-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312518201021/0001193125-18-201021-index.htm
2018-07-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312518213418/0001193125-18-213418-index.htm
2018-07-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312518225290/0001193125-18-225290-index.htm
2018-09-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312518286525/0001193125-18-286525-index.htm
2018-10-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312518291496/0001193125-18-291496-index.htm
2018-10-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312518296000/0001193125-18-296000-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1685316/000119312519035879/0001193125-19-035879-index.htm
2019-03-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312519063998/0001193125-19-063998-index.htm
2019-03-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312519092650/0001193125-19-092650-index.htm
2019-05-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312519151951/0001193125-19-151951-index.htm
2019-05-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1685316/000119312519151974/0001193125-19-151974-index.htm
2019-06-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312519176512/0001193125-19-176512-index.htm
2019-07-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312519189792/0001193125-19-189792-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312519196504/0001193125-19-196504-index.htm
2019-08-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312519214602/0001193125-19-214602-index.htm
2019-08-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1685316/000119312519214677/0001193125-19-214677-index.htm
2019-08-07F-3Registration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1685316/000119312519214685/0001193125-19-214685-index.htm
2019-08-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312519215353/0001193125-19-215353-index.htm
2019-08-096-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312519217936/0001193125-19-217936-index.htm
2019-08-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1685316/000119312519219530/0001193125-19-219530-index.htm
2019-09-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312519239420/0001193125-19-239420-index.htm
2019-09-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312519243442/0001193125-19-243442-index.htm
2019-10-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312519280483/0001193125-19-280483-index.htm
2019-11-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312519286732/0001193125-19-286732-index.htm
2019-12-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312519309473/0001193125-19-309473-index.htm
2020-01-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312520008263/0001193125-20-008263-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1685316/000119312520038131/0001193125-20-038131-index.htm
2020-03-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312520063084/0001193125-20-063084-index.htm
2020-07-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312520188775/0001193125-20-188775-index.htm
2020-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312520220400/0001193125-20-220400-index.htm
2020-09-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1685316/000119312520240537/0001193125-20-240537-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000119312520240544/0001193125-20-240544-index.htm
2020-10-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1685316/000119312520268457/0001193125-20-268457-index.htm
2018-03-0920-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1685316/000156459018005150/0001564590-18-005150-index.htm
2018-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459018013782/0001564590-18-013782-index.htm
2018-08-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459018020174/0001564590-18-020174-index.htm
2018-11-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459018028327/0001564590-18-028327-index.htm
2019-03-0520-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1685316/000156459019006137/0001564590-19-006137-index.htm
2019-05-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459019017532/0001564590-19-017532-index.htm
2019-08-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459019029617/0001564590-19-029617-index.htm
2019-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459019043218/0001564590-19-043218-index.htm
2020-03-0520-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1685316/000156459020008792/0001564590-20-008792-index.htm
2020-03-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459020012201/0001564590-20-012201-index.htm
2020-03-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459020013375/0001564590-20-013375-index.htm
2020-04-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459020015504/0001564590-20-015504-index.htm
2020-04-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459020015752/0001564590-20-015752-index.htm
2020-04-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459020016553/0001564590-20-016553-index.htm
2020-04-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459020018181/0001564590-20-018181-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459020020972/0001564590-20-020972-index.htm
2020-05-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459020023608/0001564590-20-023608-index.htm
2020-06-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459020028284/0001564590-20-028284-index.htm
2020-06-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459020028770/0001564590-20-028770-index.htm
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459020031385/0001564590-20-031385-index.htm
2020-07-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459020031752/0001564590-20-031752-index.htm
2020-08-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459020037220/0001564590-20-037220-index.htm
2020-11-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1685316/000156459020050779/0001564590-20-050779-index.htm
2017-11-20EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1685316/999999999517003032/9999999995-17-003032-index.htm
2018-03-02EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1685316/999999999518000526/9999999995-18-000526-index.htm
2018-03-07EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1685316/999999999518000546/9999999995-18-000546-index.htm
2019-08-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1685316/999999999519001884/9999999995-19-001884-index.htm